Docetaxel Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Publisher Name :
Date: 30-Apr-2020
No. of pages: 90

Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.

This report contains market size and forecasts of Docetaxel in US, including the following market information:

US Docetaxel Market Revenue, 2015-2020, 2021-2026, ($ millions)

US Docetaxel Market Consumption, 2015-2020, 2021-2026, (K Units)

US Docetaxel Production Capacity, 2015-2020, 2021-2026, (K Units)

Top Five Competitors in US Docetaxel Market 2019 (%)

The global Docetaxel market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Docetaxel market size in US was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Docetaxel manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.

This report also analyses and evaluates the COVID-19 impact on Docetaxel production and consumption in US

Total Market by Segment:

US Docetaxel Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Units)

US Docetaxel Market Segment Percentages, By Type, 2019 (%)

- 20 mg/ml

- 40 mg/ml

- 60 mg/ml

US Docetaxel Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Units)

US Docetaxel Market Segment Percentages, By Application, 2019 (%)

- Breast Cancer

- Prostate Cancer

- Non-small Cell Lung Cancer

- Other

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Docetaxel Market Competitors Revenues in US, by Players 2015-2020 (Estimated), ($ millions)

Total Docetaxel Market Competitors Revenues Share in US, by Players 2019 (%)

Total US Docetaxel Market Competitors Sales, by Players 2015-2020 (Estimated), (K Units)

Total US Docetaxel Market Competitors Sales Market Share by Players 2019 ($ millions)

Further, the report presents profiles of competitors in the market, including the following:

- Hengrui Medicine

- Sanofi

- Qilu Pharma

- Shenzhen Main Luck Pharma

Docetaxel Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Docetaxel Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 US Docetaxel Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

2 COVID-19 Impact: US Docetaxel Overall Market Size
2.1 US Docetaxel Market Size: 2020 VS 2026
2.2 US Docetaxel Revenue, Prospects & Forecasts: 2015-2026
2.3 US Docetaxel Sales (Consumption): 2015-2026

3 Company Landscape
3.1 Top Docetaxel Players in US (including Foreign and Local Companies)
3.2 Top US Docetaxel Companies Ranked by Revenue
3.3 US Docetaxel Revenue by Companies (including Foreign and Local Companies)
3.4 US Docetaxel Sales by Companies (including Foreign and Local Companies)
3.5 US Docetaxel Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Docetaxel Companies in US, by Revenue in 2019
3.7 US Manufacturers Docetaxel Product Type
3.8 Tier 1, Tier 2 and Tier 3 Docetaxel Players in US
3.8.1 List of US Tier 1 Docetaxel Companies
3.8.2 List of US Tier 2 and Tier 3 Docetaxel Companies

4 Sights by Product
4.1 Overview
4.1.1 By Type - US Docetaxel Market Size Markets, 2020 & 2026
4.1.2 20 mg/ml
4.1.3 40 mg/ml
4.1.4 60 mg/ml
4.2 By Type - US Docetaxel Revenue & Forecasts
4.2.1 By Type - US Docetaxel Revenue, 2015-2020
4.2.2 By Type - US Docetaxel Revenue, 2021-2026
4.2.3 By Type - US Docetaxel Revenue Market Share, 2015-2026
4.3 By Type - US Docetaxel Sales & Forecasts
4.3.1 By Type - US Docetaxel Sales, 2015-2020
4.3.2 By Type - US Docetaxel Sales, 2021-2026
4.3.3 By Type - US Docetaxel Sales Market Share, 2015-2026
4.4 By Type - US Docetaxel Price (Manufacturers Selling Prices), 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - US Docetaxel Market Size, 2020 & 2026
5.1.2 Breast Cancer
5.1.3 Prostate Cancer
5.1.4 Non-small Cell Lung Cancer
5.1.5 Other
5.2 By Application - US Docetaxel Revenue & Forecasts
5.2.1 By Application - US Docetaxel Revenue, 2015-2020
5.2.2 By Application - US Docetaxel Revenue, 2021-2026
5.2.3 By Application - US Docetaxel Revenue Market Share, 2015-2026
5.3 By Application - US Docetaxel Sales & Forecasts
5.3.1 By Application - US Docetaxel Sales, 2015-2020
5.3.2 By Application - US Docetaxel Sales, 2021-2026
5.3.3 By Application - US Docetaxel Sales Market Share, 2015-2026
5.4 By Application - US Docetaxel Price (Manufacturers Selling Prices), 2015-2026
6 Manufacturers & Brands Profiles
6.1 Hengrui Medicine
6.1.1 Hengrui Medicine Corporate Summary
6.1.2 Hengrui Medicine Business Overview
6.1.3 Hengrui Medicine Docetaxel Major Product Offerings
6.1.4 Hengrui Medicine Sales and Revenue in US (2015-2020)
6.1.5 Hengrui Medicine Key News
6.2 Sanofi
6.2.1 Sanofi Corporate Summary
6.2.2 Sanofi Business Overview
6.2.3 Sanofi Docetaxel Major Product Offerings
6.2.4 Sanofi Sales and Revenue in US (2015-2020)
6.2.5 Sanofi Key News
6.3 Qilu Pharma
6.3.1 Qilu Pharma Corporate Summary
6.3.2 Qilu Pharma Business Overview
6.3.3 Qilu Pharma Docetaxel Major Product Offerings
6.3.4 Qilu Pharma Sales and Revenue in US (2015-2020)
6.3.5 Qilu Pharma Key News
6.4 Shenzhen Main Luck Pharma
6.4.1 Shenzhen Main Luck Pharma Corporate Summary
6.4.2 Shenzhen Main Luck Pharma Business Overview
6.4.3 Shenzhen Main Luck Pharma Docetaxel Major Product Offerings
6.4.4 Shenzhen Main Luck Pharma Sales and Revenue in US (2015-2020)
6.4.5 Shenzhen Main Luck Pharma Key News
6.5 Jiangsu Aosaikang Pharma
6.5.1 Jiangsu Aosaikang Pharma Corporate Summary
6.5.2 Jiangsu Aosaikang Pharma Business Overview
6.5.3 Jiangsu Aosaikang Pharma Docetaxel Major Product Offerings
6.5.4 Jiangsu Aosaikang Pharma Sales and Revenue in US (2015-2020)
6.5.5 Jiangsu Aosaikang Pharma Key News

7 Docetaxel Production Capacity, Export and Import Analysis
7.1 Docetaxel Production Capacity and Value in US, Situation Analysis and Prediction, 2015-2026
7.1.1 US Docetaxel Production Capacity, 2015-2026
7.1.2 US Docetaxel Production 2015-2026
7.1.3 US Docetaxel Production Value 2015-2026
7.2 Key Local Docetaxel Manufacturers in US
7.2.1 US Key Local Docetaxel Manufacturers Production Capacity
7.2.2 US Key Local Docetaxel Manufacturers Production
7.2.3 US Key Local Docetaxel Manufacturers Production Value
7.2.4 The Proportion of Docetaxel Production Sold in US and Sold Other Than US by Manufacturers
7.3 Docetaxel Export and Import in US
7.3.1 US Docetaxel Export Market
7.3.2 US Docetaxel Source of Imports

8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints
8.1 PESTLE Analysis for US Docetaxel Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 Impact on Docetaxel Supply Chain Analysis
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Docetaxel Distributors and Sales Agents in US

10 Conclusion

11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List of Tables

Table 1. Key Players of Docetaxel in US
Table 2. Top Players in US, Ranking by Revenue (2019)
Table 3. US Docetaxel Revenue by Companies, (US$, Mn), 2015-2020
Table 4. US Docetaxel Revenue Share by Companies, 2015-2020
Table 5. US Docetaxel Sales by Companies, (K Units), 2015-2020
Table 6. US Docetaxel Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Docetaxel Price (2015-2020) (USD/Unit)
Table 8. US Manufacturers Docetaxel Product Type
Table 9. List of US Tier 1 Docetaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of US Tier 2 and Tier 3 Docetaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Docetaxel Revenue in US (US$, Mn), 2015-2020
Table 12. By Type - Docetaxel Revenue in US (US$, Mn), 2021-2026
Table 13. By Type - Docetaxel Sales in US (K Units), 2015-2020
Table 14. By Type - Docetaxel Sales in US (K Units), 2021-2026
Table 15. By Application - Docetaxel Revenue in US, (US$, Mn), 2015-2020
Table 16. By Application - Docetaxel Revenue in US, (US$, Mn), 2021-2026
Table 17. By Application - Docetaxel Sales in US, (K Units), 2015-2020
Table 18. By Application - Docetaxel Sales in US, (K Units), 2021-2026
Table 19. Hengrui Medicine Corporate Summary
Table 20. Hengrui Medicine Docetaxel Product Offerings
Table 21. Hengrui Medicine Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 22. Sanofi Corporate Summary
Table 23. Sanofi Docetaxel Product Offerings
Table 24. Sanofi Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 25. Qilu Pharma Corporate Summary
Table 26. Qilu Pharma Docetaxel Product Offerings
Table 27. Qilu Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 28. Shenzhen Main Luck Pharma Corporate Summary
Table 29. Shenzhen Main Luck Pharma Docetaxel Product Offerings
Table 30. Shenzhen Main Luck Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 31. Jiangsu Aosaikang Pharma Corporate Summary
Table 32. Jiangsu Aosaikang Pharma Docetaxel Product Offerings
Table 33. Jiangsu Aosaikang Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 34. Docetaxel Production Capacity (K Units) of Local Manufacturers in US, 2015-2020
Table 35. Docetaxel Production (K Units) of Local Manufacturers in US, 2015-2020
Table 36. US Docetaxel Production Market Share of Local Manufacturers, 2015-2020
Table 37. Docetaxel Production Value (US$, Mn) of Local Manufacturers in US, 2015-2020
Table 38. US Docetaxel Production Value Market Share of Local Manufacturers, 2015-2020
Table 39. The Percentage of Docetaxel Production Sold in US and Sold Other Than US by Manufacturers
Table 40. The Percentage of Docetaxel Production Sold in US and Sold Other Than US by Manufacturers
Table 41. Dangeguojia Docetaxel Sales (Consumption), Production, Export and Import, 2015-2020
Table 42. Raw Materials and Suppliers
Table 43. Docetaxel Downstream Clients in US
Table 44. Docetaxel Distributors and Sales Agents in US

List of Figures

Figure 1. Docetaxel Segment by Type
Figure 2. Docetaxel Segment by Application
Figure 3. Dangeguojia Docetaxel Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Docetaxel Market Size in US, (US$, Mn) & (K Units): 2020 VS 2026
Figure 6. US Docetaxel Revenue, 2015-2026 (US$, Mn)
Figure 7. Docetaxel Sales in US: 2015-2026 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Docetaxel Revenue in 2019
Figure 9. By Type - US Docetaxel Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - US Docetaxel Market Share, 2015-2020
Figure 11. By Type - US Docetaxel Market Share, 2020-2026
Figure 12. By Type - US Docetaxel Price (USD/Unit), 2015-2026
Figure 13. By Application - Docetaxel Revenue in US (US$, Mn), 2020 & 2026
Figure 14. By Application - US Docetaxel Market Share, 2015-2020
Figure 15. By Application - US Docetaxel Market Share, 2020-2026
Figure 16. By Application -US Docetaxel Price (USD/Unit), 2015-2026
Figure 17. US Docetaxel Production Capacity (K Units), 2015-2026
Figure 18. US Docetaxel Actual Output (K Units), 2015-2026
Figure 19. US Docetaxel Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of US Docetaxel Export Destination, 2019
Figure 21. The Source of Imports of US Docetaxel, 2019
Figure 22. PEST Analysis for US Docetaxel Market in 2020
Figure 23. Docetaxel Market Opportunities & Trends in US
Figure 24. Docetaxel Market Drivers in US
Figure 25. Docetaxel Market Restraints in US
Figure 26. Docetaxel Industry Value Chain
  • Global Kidney Cancer Drugs Market Insights and Forecast to 2026
    Published: 09-Jul-2020        Price: US 3900 Onwards        Pages: 181
    Kidney Cancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Kidney Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Kidney Cancer Drugs market is segmented into - Angiogenesis Inhibitors - mTOR Inhibitors ......
  • 2015-2025 Global Hydroxycarbamide Market Research by Type, End-Use and Region (COVID-19)
    Published: 09-Jul-2020        Price: US 2900 Onwards        Pages: 112
    Summary Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. The global Hydroxycarbamide market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and Segmen......
  • Global Gastric Cancer Drug Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026
    Published: 09-Jul-2020        Price: US 3200 Onwards        Pages: 163
    According to HJ Research's study, the global Gastric Cancer Drug market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Gastric Cancer Drug market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc. In this study, 2019 has been considered as the base year and 202......
  • COVID-19 Outbreak-Global Lamea Oncology/Anti-Cancer Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 09-Jul-2020        Price: US 3660 Onwards        Pages: 107
    The Lamea Oncology/Anti-Cancer Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry.Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise produ......
  • Global Immunotherapy Drugs Market Size, Status and Forecast 2020-2026
    Published: 09-Jul-2020        Price: US 3900 Onwards        Pages: 99
    Immunotherapy Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunotherapy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study - Roche - Merck - Novartis - Johnson & ......
  • COVID-19 Outbreak-Global Immunotherapy Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 09-Jul-2020        Price: US 3660 Onwards        Pages: 126
    A type of therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases.Some types of immunotherapy only target certain cells of the immune system.Others affect the immune system in a general way.The Immunotherapy Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees o......
  • Global Oxaliplatin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026
    Published: 08-Jul-2020        Price: US 5900 Onwards        Pages: 137
    Oxaliplatin market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Oxaliplatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026. Segment by Type, the Oxaliplatin market is segmented into......
  • COVID-19 Outbreak-Global Erbitux Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 07-Jul-2020        Price: US 3660 Onwards        Pages: 121
    The Erbitux market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry de......
  • Global Docetaxel Market Research Report 2020 (Covid-19 Version)
    Published: 05-Jul-2020        Price: US 3500 Onwards        Pages: 138
    Summary Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - 40 mg/ml - 20 mg/ml - 10 mg/ml By Application - Breast cancer - Non-small cell lung cancer - Prostate cancer - Gastric adenocarcinoma cancer - Head and neck cancer By Company - Sanofi-Aventis - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs